Status:
COMPLETED
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Eli Lilly and Company
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.
Detailed Description
We are using depression symptom measurements and measurements of brain electrical activity (EEG) to determine what factors may influence whether a patient is likely to show a response to antidepressan...
Eligibility Criteria
Inclusion
- Clinical diagnosis of unipolar major depression
Exclusion
- Substance abuse
- Psychotic disorder
- History of severe head trauma
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00200902
Start Date
August 1 2005
End Date
June 1 2009
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Laboratory of Brain, Behavior, and Pharmacology
Los Angeles, California, United States, 90024